BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28543802)

  • 1. Infantile bullous pemphigoid successfully treated with intravenous immunoglobulin therapy.
    Watanabe T; Hara S; Muto J; Watanabe D; Akiyama M
    Clin Exp Dermatol; 2017 Jul; 42(5):576-578. PubMed ID: 28543802
    [No Abstract]   [Full Text] [Related]  

  • 2. Infantile Bullous Pemphigoid Treated Using Intravenous Immunoglobulin: Case Report and Review of the Literature.
    Tekin B; Yücelten AD
    Pediatr Dermatol; 2015; 32(5):723-6. PubMed ID: 26119800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Half-half" blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin.
    Pacheco D; Lopes L; Soares-Almeida L; Marques MS; Filipe P
    Acta Dermatovenerol Alp Pannonica Adriat; 2012 Sep; 21(3):59-61. PubMed ID: 23267874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory bullous pemphigoid with fatal outcome in a young patient.
    Cruz MJ; Santos P; Morais P; Barreto F; Azevedo F
    Int J Dermatol; 2013 May; 52(5):601-2. PubMed ID: 23590375
    [No Abstract]   [Full Text] [Related]  

  • 5. Postvaccinal, corticosteroid-resistant bullous pemphigoid in infancy: treatment with intravenous immunoglobulin.
    Ister M; Pouessel G; Ythier H; Catteau B; Carpentier O
    Pediatr Dermatol; 2014; 31(4):e94-5. PubMed ID: 24916151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of prednisolone and i.v. immunoglobulin treatment decreases circulating interleukin-5 and eosinophils in a patient with bullous pemphigoid.
    Yamashita C; Nakamizo S; Honda Y; Dainichi T; Kabashima K
    J Dermatol; 2017 Jan; 44(1):101-102. PubMed ID: 27154738
    [No Abstract]   [Full Text] [Related]  

  • 7. Refractory antilaminin γ1 pemphigoid successfully treated with intravenous immunoglobulin and mycophenolate mofetil.
    Alloo A; Strazzula L; Rothschild B; Hawryluk E; Levine D; Hoang MP; Koga H; Hashimoto T; Kroshinsky D
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1401-3. PubMed ID: 24397852
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid.
    Amagai M; Ikeda S; Hashimoto T; Mizuashi M; Fujisawa A; Ihn H; Matsuzaki Y; Ohtsuka M; Fujiwara H; Furuta J; Tago O; Yamagami J; Tanikawa A; Uhara H; Morita A; Nakanishi G; Tani M; Aoyama Y; Makino E; Muto M; Manabe M; Konno T; Murata S; Izaki S; Watanabe H; Yamaguchi Y; Matsukura S; Seishima M; Habe K; Yoshida Y; Kaneko S; Shindo H; Nakajima K; Kanekura T; Takahashi K; Kitajima Y; Hashimoto K;
    J Dermatol Sci; 2017 Feb; 85(2):77-84. PubMed ID: 27876358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bullous pemphigoid (BP) in an infant complicated by tuberculous meningoencephalitis.
    Nanda A; Nanda M; Dvorak R; Al-Sabah H; Alsaleh QA
    Int J Dermatol; 2007 Sep; 46(9):964-6. PubMed ID: 17822503
    [No Abstract]   [Full Text] [Related]  

  • 10. Infantile bullous pemphigoid successfully treated with combined pulse corticosteroids and high-dose IVIG.
    Wawrzycki B; Krasowska D; Pietrzak A; Szumilo J; Blazowski L; Pietraszek-Mamcarz J; Lotti T
    Dermatol Ther; 2018 Sep; 31(5):e12635. PubMed ID: 30216603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood bullous pemphigoid treated by i.v. immunoglobulin.
    Xiao T; Li B; Wang YK; He CD; Chen HD
    J Dermatol; 2007 Sep; 34(9):650-3. PubMed ID: 17727369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence case of bullous pemphigoid and pemphigus foliaceus.
    Tsujiwaki M; Abe R; Nomura Y; Nishimura M; Hoshina D; Shinkuma S; Natsuga K; Ujiie H; Arita K; Shimizu H
    Eur J Dermatol; 2013; 23(4):552-3. PubMed ID: 24001742
    [No Abstract]   [Full Text] [Related]  

  • 13. Bullous pemphigoid in a patient with multiple sclerosis being treated with human immunoglobulin.
    Massa AF; Varela P; Osório-Ferreira E; Nora M; Couceiro A; Baptista A
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):821-2. PubMed ID: 24588974
    [No Abstract]   [Full Text] [Related]  

  • 14. Infantile bullous pemphigoid treated with intravenous immunoglobulin therapy.
    Sugawara N; Nagai Y; Matsushima Y; Aoyama K; Ishikawa O
    J Am Acad Dermatol; 2007 Dec; 57(6):1084-9. PubMed ID: 17889964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory childhood pemphigoid successfully treated with rituximab.
    Fuertes I; Luelmo J; Leal L; Romaní J; Sánchez S; Mascaró JM
    Pediatr Dermatol; 2013; 30(5):e96-7. PubMed ID: 23278674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A resistant case of pemphigus gestationis successfully treated with intravenous immunoglobulin plus cyclosporine.
    Hapa A; Gurpinar A; Akan T; Gokoz O
    Int J Dermatol; 2014 Apr; 53(4):e269-71. PubMed ID: 23879601
    [No Abstract]   [Full Text] [Related]  

  • 17. Bullous Pemphigoid in Three Paediatric Patients in Finland.
    Pankakoski A; Panelius J; Salava A; Kluger N
    Acta Derm Venereol; 2020 Mar; 100(6):adv00086. PubMed ID: 32157316
    [No Abstract]   [Full Text] [Related]  

  • 18. Pemphigus foliaceus progressing to bullous pemphigoid.
    Iwakura R; Oiso N; Tateishi C; Suzuki M; Uchida S; Yanagihara S; Hashimoto T; Tsuruta D; Kawada A
    J Dermatol; 2019 Nov; 46(11):e424-e426. PubMed ID: 31342555
    [No Abstract]   [Full Text] [Related]  

  • 19. Infantile bullous pemphigoid successfully treated with i.v. immunoglobulin and cyclosporin.
    Okada K; Kakeda M; Yamamoto S; Yokoyama T; Habe K; Nakato D; Hirayama M; Mizutani H; Yamanaka K
    J Dermatol; 2019 Jun; 46(6):e213-e214. PubMed ID: 30536915
    [No Abstract]   [Full Text] [Related]  

  • 20. Case of bullous pemphigoid coexisting with anti-desmoglein autoantibodies.
    Tie D; Yoshida T; Chinuki Y; Da X; Ishikawa N; Morita E
    J Dermatol; 2017 Jul; 44(7):822-825. PubMed ID: 28342216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.